文献速递头颈外科

头颈癌放疗后纤维化的治疗干预:系统综述

Therapeutic Interventions for Radiation-Induced Fibrosis in Head and Neck Cancer Patients: A Systematic Review.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-09-11

本系统综述评估头颈癌治疗后放疗诱导纤维化的各种治疗。检索四个数据库后纳入8项研究,药物干预包括己酮可可碱-生育酚、普伐他汀、氨磷汀和局部超氧化物歧化酶,操作干预包括脂肪移植和微电流治疗。各研究纤维化改善率差异大,研究设计和结局测量异质性显著限制比较有效性结论。

要点

  • 己酮可可碱-生育酚在非对照试验中83%患者纤维化面积减少≥50%。
  • 普伐他汀使35.7%患者纤维化厚度减少≥30%。
  • 脂肪移植97%患者(n=38)躯体改善,微电流治疗92%患者(n=26)颈部活动改善。

核心结论

  • 现有治疗对头颈癌纤维化的改善程度研究间差异大,研究设计和结局测量异质性显著限制比较有效性结论。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索Medline、Embase.com、Web of Science和Cochrane Library,初筛4078条标题摘要,全文审阅147篇,最终纳入8篇符合标准的研究。

主要发现

  • 药物干预包括己酮可可碱-生育酚、普伐他汀、氨磷汀和局部超氧化物歧化酶(SOD),各研究纤维化改善率不一。
  • 一项非对照试验中,83%接受己酮可可碱-生育酚的患者纤维化表面积减少≥50%。
  • 普伐他汀使35.7%患者纤维化厚度减少≥30%。
  • 操作干预包括脂肪移植和微电流治疗,脂肪移植与97%患者(n=38)的躯体改善相关。
  • 微电流治疗使92%患者(n=26)颈部活动度改善。

临床怎么用

  • 己酮可可碱-生育酚、普伐他汀、脂肪移植和微电流治疗在不同研究中显示对放疗后纤维化有改善作用,但证据异质性大,临床决策需结合个体情况。

局限性

  • 研究设计异质性大,结局测量不一致,限制比较有效性结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review and evaluate treatments for radiation-induced fibrosis (RIF) following head and neck cancer (HNC) therapy. DATA SOURCES: Medline, Embase.com, Web of Science, and Cochrane Library. REVIEW METHODS: A systematic review was conducted on the management of HNC RIF using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Descriptive synthesis was conducted to summarize treatment efficacy. RESULTS: After initial screening of 4078 titles and abstracts, 147 full-text articles were reviewed, with eight meeting inclusion criteria. Pharmacological interventions included pentoxifylline-tocopherol, pravastatin, amifostine, and topical superoxide dismutase (SOD). Pentoxifylline-tocopherol, pravastatin, and amifostine demonstrated variable fibrosis improvement rates across studies. In one uncontrolled trial, 83% of patients receiving pentoxifylline-tocopherol achieved ≥50% reduction in measured fibrotic surface area, and pravastatin reduced fibrosis thickness by ≥30% in 35.7% of patients. Procedural interventions included lipotransfer and microcurrent therapy, with lipotransfer associated with physical improvements in 97% of patients (n = 38) and microcurrent therapy enhancing cervical mobility in 92% of patients (n = 26). CONCLUSION: Improvements in HNC fibrosis after current treatments ranged widely across studies; however, substantial heterogeneity in study design and outcome measurement limits definitive conclusions regarding comparative effectiveness.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Reddy PD, Rumde P, Helou V, et al. Therapeutic Interventions for Radiation-Induced Fibrosis in Head and Neck Cancer Patients: A Systematic Review. Otolaryngol Head Neck Surg. 2026. PMID: 42726929. doi:10.1002/ohn.70436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。